Tags

Type your tag names separated by a space and hit enter

Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".
Hepat Mon 2014; 14(5):e17641HM

Abstract

CONTEXT

Nonalcoholic Fatty Liver Disease (NAFLD) is the major chronic liver disease in the pediatric population. NAFLD includes a broad spectrum of abnormalities (inflammation, fibrosis and cirrhosis), ranging from accumulation of fat (also known as steatosis) towards non-alcoholic steatohepatitis (NASH). The development of NAFLD in children is significantly increased.

EVIDENCE ACQUISITION

A literature search of electronic databases was undertaken for the major studies published from 1998 to today. The databases searched were: PubMed, EMBASE, Orphanet, Midline and Cochrane Library. We used the key words: "non-alcoholic fatty liver disease, children, non-alcoholic steatohepatitis and fatty liver".

RESULTS

NAFLD/NASH is probably promoted by "multiple parallel hits": environmental and genetic factors, systemic immunological disorders (oxidative stress, persistent-low grade of inflammation) as well as obesity and metabolic alterations (insulin resistance and metabolic syndrome). However its exact cause still underdiagnosed and unknown.

CONCLUSIONS

Pediatric NAFLD/NASH is emerging problem. Longitudinal follow-up studies, unfortunately still insufficient, are needed to better understand the natural history and outcome of NAFLD in children. This review focuses on the current knowledge regarding the epidemiology, pathogenesis, environmental, genetic and metabolic factors of disease. The review also highlights the importance of studying the underlying mechanisms of pediatric NAFLD and the need for complete and personalized approach in the management of NAFLD/NASH.

Authors+Show Affiliations

Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.Department of Pediatric Sciences, Genetics and Pediatric Immunology Unit, University of Messina, Messina, Italy.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24829591

Citation

Manti, Sara, et al. "Nonalcoholic Fatty Liver Disease/non-alcoholic Steatohepatitis in Childhood: Endocrine-metabolic "mal-programming"." Hepatitis Monthly, vol. 14, no. 5, 2014, pp. e17641.
Manti S, Romano C, Chirico V, et al. Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". Hepat Mon. 2014;14(5):e17641.
Manti, S., Romano, C., Chirico, V., Filippelli, M., Cuppari, C., Loddo, I., ... Arrigo, T. (2014). Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". Hepatitis Monthly, 14(5), pp. e17641. doi:10.5812/hepatmon.17641.
Manti S, et al. Nonalcoholic Fatty Liver Disease/non-alcoholic Steatohepatitis in Childhood: Endocrine-metabolic "mal-programming". Hepat Mon. 2014;14(5):e17641. PubMed PMID: 24829591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". AU - Manti,Sara, AU - Romano,Claudio, AU - Chirico,Valeria, AU - Filippelli,Martina, AU - Cuppari,Caterina, AU - Loddo,Italia, AU - Salpietro,Carmelo, AU - Arrigo,Teresa, Y1 - 2014/05/01/ PY - 2014/01/17/received PY - 2014/02/13/revised PY - 2014/02/19/accepted PY - 2014/5/16/entrez PY - 2014/5/16/pubmed PY - 2014/5/16/medline KW - Mallory Bodies KW - Non-Alcoholic Fatty Liver Disease KW - Oxidative Stress SP - e17641 EP - e17641 JF - Hepatitis monthly JO - Hepat Mon VL - 14 IS - 5 N2 - CONTEXT: Nonalcoholic Fatty Liver Disease (NAFLD) is the major chronic liver disease in the pediatric population. NAFLD includes a broad spectrum of abnormalities (inflammation, fibrosis and cirrhosis), ranging from accumulation of fat (also known as steatosis) towards non-alcoholic steatohepatitis (NASH). The development of NAFLD in children is significantly increased. EVIDENCE ACQUISITION: A literature search of electronic databases was undertaken for the major studies published from 1998 to today. The databases searched were: PubMed, EMBASE, Orphanet, Midline and Cochrane Library. We used the key words: "non-alcoholic fatty liver disease, children, non-alcoholic steatohepatitis and fatty liver". RESULTS: NAFLD/NASH is probably promoted by "multiple parallel hits": environmental and genetic factors, systemic immunological disorders (oxidative stress, persistent-low grade of inflammation) as well as obesity and metabolic alterations (insulin resistance and metabolic syndrome). However its exact cause still underdiagnosed and unknown. CONCLUSIONS: Pediatric NAFLD/NASH is emerging problem. Longitudinal follow-up studies, unfortunately still insufficient, are needed to better understand the natural history and outcome of NAFLD in children. This review focuses on the current knowledge regarding the epidemiology, pathogenesis, environmental, genetic and metabolic factors of disease. The review also highlights the importance of studying the underlying mechanisms of pediatric NAFLD and the need for complete and personalized approach in the management of NAFLD/NASH. SN - 1735-143X UR - https://www.unboundmedicine.com/medline/citation/24829591/Nonalcoholic_Fatty_liver_disease/non_alcoholic_steatohepatitis_in_childhood:_endocrine_metabolic_"mal_programming"_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24829591/ DB - PRIME DP - Unbound Medicine ER -